Madrigal Pharmaceuticals, Inc.涨2.25% 股价突破300美元大关

市场透视12-20 22:44

北京时间2024年12月20日22时44分，Madrigal Pharmaceuticals, Inc.（MDGL.us）股票出现异动，股价大幅拉升2.25%。截至发稿，该股报300.00美元/股，成交量3.5931万股，换手率0.16%，振幅2.26%。最近的财报数据显示，该股实现营业收入62.18百万美元，净利润-1.07亿美元，每股收益-4.92美元，毛利59.73百万美元，市盈率-...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2492440234?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-12-20 22:44","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2492440234","market":"us","top_or_hot":-1,"title":"Madrigal Pharmaceuticals, Inc.涨2.25% 股价突破300美元大关","media":"市场透视","content":"<div>\n<p>北京时间2024年12月20日22时44分，Madrigal Pharmaceuticals, Inc.（MDGL.us）股票出现异动，股价大幅拉升2.25%。截至发稿，该股报300.00美元/股，成交量3.5931万股，换手率0.16%，振幅2.26%。最近的财报数据显示，该股实现营业收入62.18百万美元，净利润-1.07亿美元，每股收益-4.92美元，毛利59.73百万美元，市盈率-...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220224429984cfc8b&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Madrigal Pharmaceuticals, Inc.涨2.25% 股价突破300美元大关</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMadrigal Pharmaceuticals, Inc.涨2.25% 股价突破300美元大关\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-20 22:44 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220224429984cfc8b&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年12月20日22时44分，Madrigal Pharmaceuticals, Inc.（MDGL.us）股票出现异动，股价大幅拉升2.25%。截至发稿，该股报300.00美元/股，成交量3.5931万股，换手率0.16%，振幅2.26%。最近的财报数据显示，该股实现营业收入62.18百万美元，净利润-1.07亿美元，每股收益-4.92美元，毛利59.73百万美元，市盈率-...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220224429984cfc8b&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4588","symbol_name":"碎股","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220224429984cfc8b&s=b","article_id":"2492440234","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220224429984cfc8b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2492440234","pubTimestamp":1734705869,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年12月20日22时44分，Madrigal Pharmaceuticals, Inc.股票出现异动，股价大幅拉升2.25%。Madrigal Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.43%。其相关个股中，Humacyte, Inc.、Psyence Biomedical Ltd.、Humacyte Inc C/Wts 27/08/2026 涨幅较大，Psyence Biomedical Ltd.、Aptose Biosciences, Inc.、Aditxt, Inc.较为活跃，换手率分别为1944.01%、88.89%、55.82%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Humacyte, Inc.、Aptose Biosciences, Inc.，振幅分别为54.97%、35.26%、34.90%。Madrigal Pharmaceuticals, Inc.公司简介：Madrigal Pharmaceuticals Inc是一家临床阶段生物制药公司。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4588":"碎股","BK4139":"生物科技","BK4585":"ETF&股票定投概念","MDGL":"Madrigal Pharmaceuticals, Inc."},"translate_title":"Madrigal Pharmaceuticals, Inc. rises 2.25%, stock tops the $300 mark","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MDGL":1},"content_text":"北京时间2024年12月20日22时44分，Madrigal Pharmaceuticals, Inc.（MDGL.us）股票出现异动，股价大幅拉升2.25%。截至发稿，该股报300.00美元/股，成交量3.5931万股，换手率0.16%，振幅2.26%。最近的财报数据显示，该股实现营业收入62.18百万美元，净利润-1.07亿美元，每股收益-4.92美元，毛利59.73百万美元，市盈率-11.95倍。机构评级方面，在所有16家参与评级的机构中，81%的券商给予买入建议，13%的券商给予持有建议，6%的券商给予卖出建议。Madrigal Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.43%。其相关个股中，Humacyte, Inc.、Psyence Biomedical Ltd.、Humacyte Inc C/Wts 27/08/2026 (To Pur Com)涨幅较大，Psyence Biomedical Ltd.、Aptose Biosciences, Inc.、Aditxt, Inc.较为活跃，换手率分别为1944.01%、88.89%、55.82%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029(To Pur Com)、Humacyte, Inc.、Aptose Biosciences, Inc.，振幅分别为54.97%、35.26%、34.90%。Madrigal Pharmaceuticals, Inc.公司简介：Madrigal Pharmaceuticals Inc是一家临床阶段生物制药公司。它着重于心血管疾病和非酒精性脂肪性肝炎（NASH）的治疗剂开发及其商业化。该公司的产品MGL-3196，是一种口服小分子针对肝脏的β选择性THR激动剂，用于治疗非酒精性脂肪性肝炎和家族性高胆固醇血症。此外，MGL-3196还通过增加脂肪代谢来降低血浆和肝脏中的甘油三酯并展现出抗糖尿病作用。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2492440234"}